Metropolis Healthcare Limited
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more
Metropolis Healthcare Limited (METROPOLIS) - Total Assets
Latest total assets as of September 2025: ₹19.93 Billion INR
Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) holds total assets worth ₹19.93 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Metropolis Healthcare Limited - Total Assets Trend (2014–2025)
This chart illustrates how Metropolis Healthcare Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Metropolis Healthcare Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Metropolis Healthcare Limited's total assets of ₹19.93 Billion consist of 18.5% current assets and 81.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹29.73 Million | 2.1% |
| Accounts Receivable | ₹1.48 Billion | 7.9% |
| Inventory | ₹478.41 Million | 2.6% |
| Property, Plant & Equipment | ₹3.61 Billion | 19.3% |
| Intangible Assets | ₹4.97 Billion | 26.6% |
| Goodwill | ₹5.90 Billion | 31.6% |
Asset Composition Trend (2014–2025)
This chart illustrates how Metropolis Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Metropolis Healthcare Limited's current assets represent 18.5% of total assets in 2025, a decrease from 58.2% in 2014.
- Cash Position: Cash and equivalents constituted 2.1% of total assets in 2025, down from 6.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, an increase from 9.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 31.6% of total assets.
Metropolis Healthcare Limited Competitors by Total Assets
Key competitors of Metropolis Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Metropolis Healthcare Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Metropolis Healthcare Limited generates 0.71x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Metropolis Healthcare Limited generates $7.76 in net profit.
Metropolis Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.64 | 2.65 |
| Quick Ratio | 1.02 | 1.49 | 2.49 |
| Cash Ratio | 0.20 | 0.23 | 0.00 |
| Working Capital | ₹486.06 Million | ₹ 1.53 Billion | ₹ 3.14 Billion |
Metropolis Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Metropolis Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.23 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 20.1% |
| Total Assets | ₹18.67 Billion |
| Market Capitalization | $557.10 Million USD |
Valuation Analysis
Below Book Valuation: The market values Metropolis Healthcare Limited's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Metropolis Healthcare Limited's assets grew by 20.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Metropolis Healthcare Limited (2014–2025)
The table below shows the annual total assets of Metropolis Healthcare Limited from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹18.67 Billion | +20.08% |
| 2024-03-31 | ₹15.55 Billion | +3.56% |
| 2023-03-31 | ₹15.02 Billion | -1.87% |
| 2022-03-31 | ₹15.30 Billion | +52.36% |
| 2021-03-31 | ₹10.04 Billion | +33.52% |
| 2020-03-31 | ₹7.52 Billion | +36.12% |
| 2019-03-31 | ₹5.53 Billion | +4.20% |
| 2018-03-31 | ₹5.30 Billion | +2.95% |
| 2017-03-31 | ₹5.15 Billion | +30.12% |
| 2016-03-31 | ₹3.96 Billion | -14.58% |
| 2015-03-31 | ₹4.64 Billion | +18.07% |
| 2014-03-31 | ₹3.93 Billion | -- |